Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) currently has a daily average trading volume of 926.77K but it saw 1234171 shares traded in last market. With a market cap of 42.09B USD, the company’s current market price of $322.81 came rising about 3.76 while comparing to the previous closing price of $311.12. In past 52 weeks, the stock remained buoying in the range of price level as high as $333.70 and as low as $205.87. In the recent trading on the day, stock has struck highest price mark of $311.255 while lowest mark touched by it was $323.41.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Redburn Atlantic which initiated the stock as “Buy” in its note to investors issued on March 31, 2025, recommending a price target of $353 for it. JP Morgan upgraded its recommendation for the stock as a “Overweight” from “Neutral” on March 24, 2025 while assigning a price target range of $280-$328.
Over the week, ALNY’s stock price is moving 0.60% up while it is 4.81% when we observe its performance for the past one month. Year-to-date it is 23.91% up and over the past year, the stock is showing an upside performance of 37.18%.
Currently, Alnylam Pharmaceuticals Inc’s total number of outstanding shares is 130.31M. Company’s return on investment (ROI) stands at -9.95%. It has a 138.64 of forward P/E ratio. Stock’s beta reads 0.24. Stock has a price to book (P/B) ratio of 364.41 while price to sale or P/S ratio amounts to 17.93. Its return on asset (ROA) is -6.71% on average.
